-
1
-
-
0027945314
-
Current management of unresectable non-small cell lung cancer
-
[discussion 11-3]
-
Livingston R.B. Current management of unresectable non-small cell lung cancer. Semin Oncol 21 (1994) 4-11 [discussion 11-3]
-
(1994)
Semin Oncol
, vol.21
, pp. 4-11
-
-
Livingston, R.B.1
-
2
-
-
0036194111
-
Therapy for Stage IIIB and Stage IV non-small cell lung cancer
-
Kim T.E., and Murren J.R. Therapy for Stage IIIB and Stage IV non-small cell lung cancer. Clin Chest Med 23 (2002) 209-224
-
(2002)
Clin Chest Med
, vol.23
, pp. 209-224
-
-
Kim, T.E.1
Murren, J.R.2
-
3
-
-
0034220252
-
Chemotherapy in metastatic non-small-cell lung cancer
-
Sandler A. Chemotherapy in metastatic non-small-cell lung cancer. Oncology (Huntingt) 14 (2000) 15-27
-
(2000)
Oncology (Huntingt)
, vol.14
, pp. 15-27
-
-
Sandler, A.1
-
4
-
-
0028843552
-
Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
-
Non-small Cell Lung Cancer Collaborative Group
-
Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311 (1995) 899-909
-
(1995)
BMJ
, vol.311
, pp. 899-909
-
-
-
5
-
-
0027367248
-
Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?
-
Grilli R., Oxman A.D., and Julian J.A. Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?. J Clin Oncol 11 (1993) 1866-1872
-
(1993)
J Clin Oncol
, vol.11
, pp. 1866-1872
-
-
Grilli, R.1
Oxman, A.D.2
Julian, J.A.3
-
6
-
-
0028031433
-
Chemotherapy vs. supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature
-
Marino P., Pampallona S., Preatoni A., Cantoni A., and Invernizzi F. Chemotherapy vs. supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature. Chest 106 (1994) 861-865
-
(1994)
Chest
, vol.106
, pp. 861-865
-
-
Marino, P.1
Pampallona, S.2
Preatoni, A.3
Cantoni, A.4
Invernizzi, F.5
-
7
-
-
0027210487
-
Polychemotherapy in advanced non small cell lung cancer: a meta-analysis
-
Souquet P.J., Chauvin F., Boissel J.P., Cellerino R., Cormier Y., Ganz P.A., et al. Polychemotherapy in advanced non small cell lung cancer: a meta-analysis. Lancet 342 (1993) 19-21
-
(1993)
Lancet
, vol.342
, pp. 19-21
-
-
Souquet, P.J.1
Chauvin, F.2
Boissel, J.P.3
Cellerino, R.4
Cormier, Y.5
Ganz, P.A.6
-
8
-
-
0042413836
-
Randomized multimatrional, Phase III study of docetaxel plus platinum combinations versus vinorebline plus cisplatin for advanced non small cell lung cancer: the TAX 326 study group
-
Fossella F., Pereira J.R., von Pawel J., Pluzanska A., Gorbounova V., Kaukel E., et al. Randomized multimatrional, Phase III study of docetaxel plus platinum combinations versus vinorebline plus cisplatin for advanced non small cell lung cancer: the TAX 326 study group. J Clin Oncol 21 (2003) 3016-3024
-
(2003)
J Clin Oncol
, vol.21
, pp. 3016-3024
-
-
Fossella, F.1
Pereira, J.R.2
von Pawel, J.3
Pluzanska, A.4
Gorbounova, V.5
Kaukel, E.6
-
9
-
-
0033369094
-
New options in the treatment of non-small cell lung cancer
-
Fossella F., Rigas J.R., and Belani C.P. New options in the treatment of non-small cell lung cancer. Anticancer Drugs 10 (1999) S25-S28
-
(1999)
Anticancer Drugs
, vol.10
-
-
Fossella, F.1
Rigas, J.R.2
Belani, C.P.3
-
10
-
-
1842715876
-
Phase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for Stage III unresectable non-small-cell lung cancer: a Vanderbilt cancer center affiliate network (VCCAN) trial
-
Choy H., DeVore R.F., Hande K.R., Porter L.L., Rosenblatt P.A., Slovis B., et al. Phase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for Stage III unresectable non-small-cell lung cancer: a Vanderbilt cancer center affiliate network (VCCAN) trial. Lung Cancer 34 (2001) 441-449
-
(2001)
Lung Cancer
, vol.34
, pp. 441-449
-
-
Choy, H.1
DeVore, R.F.2
Hande, K.R.3
Porter, L.L.4
Rosenblatt, P.A.5
Slovis, B.6
-
11
-
-
1542713370
-
Gefitnib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a Phase III trial-INTACT 2
-
Herbst R.S., Giaccone G., Schiller J.H., Natale R.B., Miller V., Manegold C., et al. Gefitnib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a Phase III trial-INTACT 2. J Clin Oncol 22 (2004) 785-794
-
(2004)
J Clin Oncol
, vol.22
, pp. 785-794
-
-
Herbst, R.S.1
Giaccone, G.2
Schiller, J.H.3
Natale, R.B.4
Miller, V.5
Manegold, C.6
-
12
-
-
0034594628
-
New guidelines to evaluate the response to treatment in solid tumors
-
Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S., Rubinstein L., et al. New guidelines to evaluate the response to treatment in solid tumors. J NCI 92 (2000) 205-216
-
(2000)
J NCI
, vol.92
, pp. 205-216
-
-
Therasse, P.1
Arbuck, S.G.2
Eisenhauer, E.A.3
Wanders, J.4
Kaplan, R.S.5
Rubinstein, L.6
-
13
-
-
33845382806
-
Nonparametric estimation from incomplete observations
-
Kaplan E., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
-
(1958)
J Am Stat Assoc
, vol.53
, pp. 457-481
-
-
Kaplan, E.1
Meier, P.2
-
14
-
-
0000647322
-
Prognostic factors in advanced NSCLC: analysis of ECOG trials from 1981 to 1992
-
Jiroutek M., Johnson D., Blum R., Bonomi P., Chang A., Ettinger P., et al. Prognostic factors in advanced NSCLC: analysis of ECOG trials from 1981 to 1992. Proc Am Soc Clin Oncol 17 (1998) 1774
-
(1998)
Proc Am Soc Clin Oncol
, vol.17
, pp. 1774
-
-
Jiroutek, M.1
Johnson, D.2
Blum, R.3
Bonomi, P.4
Chang, A.5
Ettinger, P.6
-
15
-
-
0035889915
-
Outcome of patients with a performance status of 2 in ECOG study E1594: a Phase III trial in patients with metastatic NSCLC
-
Sweeney C.J., Zhu J., Sandler A.B., Schiller J., Belani C.P., Langer C., et al. Outcome of patients with a performance status of 2 in ECOG study E1594: a Phase III trial in patients with metastatic NSCLC. Cancer 92 (2001) 2639-2647
-
(2001)
Cancer
, vol.92
, pp. 2639-2647
-
-
Sweeney, C.J.1
Zhu, J.2
Sandler, A.B.3
Schiller, J.4
Belani, C.P.5
Langer, C.6
-
16
-
-
10044221756
-
ECOS 1599: randomized Phase II study of paclitaxel/Carboplatin vs. Cisplatin/gemcitabine in PS2 patients with NSCLC
-
Tester W.J., Stephenson P., Langer C.J., Schiller J.H., Johnson D.H., and Rapoport B.L. ECOS 1599: randomized Phase II study of paclitaxel/Carboplatin vs. Cisplatin/gemcitabine in PS2 patients with NSCLC. Proc Am Soc Clin Oncol 23 (2004) 627
-
(2004)
Proc Am Soc Clin Oncol
, vol.23
, pp. 627
-
-
Tester, W.J.1
Stephenson, P.2
Langer, C.J.3
Schiller, J.H.4
Johnson, D.H.5
Rapoport, B.L.6
-
17
-
-
2342469070
-
Addressing the optimal number of cytotoxic agents in Stage IIA/IV NSCLC: a metanalysis of the published literature
-
Baggstrom M.Q., Socinski M.A., Hensing T.A., and Poole C. Addressing the optimal number of cytotoxic agents in Stage IIA/IV NSCLC: a metanalysis of the published literature. Proc Am Soc Clin Oncol 22 (2003) 624
-
(2003)
Proc Am Soc Clin Oncol
, vol.22
, pp. 624
-
-
Baggstrom, M.Q.1
Socinski, M.A.2
Hensing, T.A.3
Poole, C.4
-
18
-
-
0003275345
-
Single-agent vs. combination chemotherapy in advanced NSCLC: a CALGB randomized trial of efficacy, quality of life and cost effectiveness
-
Lilenbaum R.C., Herndon J., List M., Desch C., Watson D., Holland J., et al. Single-agent vs. combination chemotherapy in advanced NSCLC: a CALGB randomized trial of efficacy, quality of life and cost effectiveness. Proc Am Soc Clin Oncol 21 (2002) 2
-
(2002)
Proc Am Soc Clin Oncol
, vol.21
, pp. 2
-
-
Lilenbaum, R.C.1
Herndon, J.2
List, M.3
Desch, C.4
Watson, D.5
Holland, J.6
-
19
-
-
10044289201
-
Gemcitabine vs. gemcitabine carboplatin for patients with advanced NSCLC and PS 2. A prospective randomized Phase II study of the Hellemic Co-operative Oncology Group
-
Kosmidis P.A., Dimopoulos M.A., Syrigos C., Nicolaides C., Aravantinos G., Boukovinas I., et al. Gemcitabine vs. gemcitabine carboplatin for patients with advanced NSCLC and PS 2. A prospective randomized Phase II study of the Hellemic Co-operative Oncology Group. Proc Am Soc Clin Oncol 23 (2004) 627
-
(2004)
Proc Am Soc Clin Oncol
, vol.23
, pp. 627
-
-
Kosmidis, P.A.1
Dimopoulos, M.A.2
Syrigos, C.3
Nicolaides, C.4
Aravantinos, G.5
Boukovinas, I.6
-
20
-
-
10044272817
-
Preliminary results of a Phase II trial utilizing gemcitabine in patients with advanced non-small cell lung cancer and a performance status 2
-
Neubauer M.A., Reynolds C.H., Joppert M., Whittaker T., Ahmad Y.H., Ghaddar H., et al. Preliminary results of a Phase II trial utilizing gemcitabine in patients with advanced non-small cell lung cancer and a performance status 2. Proc Am Soc Clin Oncol 23 (2004) 643
-
(2004)
Proc Am Soc Clin Oncol
, vol.23
, pp. 643
-
-
Neubauer, M.A.1
Reynolds, C.H.2
Joppert, M.3
Whittaker, T.4
Ahmad, Y.H.5
Ghaddar, H.6
|